Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelial mineralocorticoid receptor ablation does not alter blood pressure, kidney function or renal vessel contractility
Sidsel B. Laursen, Stine H. Finsen, Niels Marcussen, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0193032-e0193032
Open Access | Times Cited: 19

Showing 19 citing articles:

Diet-Induced Obesity Promotes Kidney Endothelial Stiffening and Fibrosis Dependent on the Endothelial Mineralocorticoid Receptor
Annayya R. Aroor, Javad Habibi, Ravi Nistala, et al.
Hypertension (2019) Vol. 73, Iss. 4, pp. 849-858
Open Access | Times Cited: 52
Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
Toshifumi Nakamura, Sophie Girerd, Frédéric Jaisser, et al.
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 12-18
Open Access | Times Cited: 26
Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
Johann Bauersachs, Achim Lother
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 19-26
Open Access | Times Cited: 23
The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease
M. Elizabeth Moss, Brigett Carvajal, Iris Z. Jaffe
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107387-107387
Open Access | Times Cited: 40
miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes
Renzhi Hu, Xuan Li, Chuan Peng, et al.
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001101-e001101
Open Access | Times Cited: 29
Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle
Lauren A. Biwer, Mary C. Wallingford, Iris Z. Jaffe
American Journal of Hypertension (2018) Vol. 32, Iss. 2, pp. 123-134
Open Access | Times Cited: 29
Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor
Anders Bach, Bettina Hjelm Clausen, Lotte K. Kristensen, et al.
Neuropharmacology (2019) Vol. 150, pp. 100-111
Open Access | Times Cited: 26
Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension
Jessica Faulkner, Eric J. Belin de Chantemèle
Current Hypertension Reports (2019) Vol. 21, Iss. 10
Open Access | Times Cited: 24
Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease
Sarah Spencer, Caroline Wheeler‐Jones, Jonathan Elliott
Journal of Veterinary Pharmacology and Therapeutics (2020) Vol. 43, Iss. 3, pp. 243-267
Open Access | Times Cited: 19
Vascular mineralocorticoid receptor activation and disease
Jonatan Barrera‐Chimal, Frédéric Jaisser
Experimental Eye Research (2019) Vol. 188, pp. 107796-107796
Open Access | Times Cited: 18
Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease
Nicole L. Wolter, Iris Z. Jaffe
AJP Cell Physiology (2022) Vol. 324, Iss. 1, pp. C193-C204
Open Access | Times Cited: 10
Histamine H2-receptor antagonism improves conduit artery endothelial function and reduces plasma aldosterone level without lowering arterial blood pressure in angiotensin II–hypertensive mice
Kasper Bostlund Assersen, Boye L. Jensen, Camilla Enggaard, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 3, pp. 307-321
Open Access | Times Cited: 1
Molecular Mechanisms of Primary Aldosteronism
Sergei G. Tevosian, Shawna Fox, Hans K. Ghayee
Endocrinology and Metabolism (2019) Vol. 34, Iss. 4, pp. 355-355
Open Access | Times Cited: 9
Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice
Agnieszka Kij, Anna Bar, Kamil Przyborowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8664-8664
Open Access | Times Cited: 7
The invention of aldosterone, how the past resurfaces in pediatric endocrinology
Say Viengchareun, Eric Pussard, Mireille Castanet, et al.
Molecular and Cellular Endocrinology (2021) Vol. 535, pp. 111375-111375
Open Access | Times Cited: 4
Correction to: Histamine H2‑receptor antagonism improves conduit artery endothelial function and reduces plasma aldosterone level without lowering arterial blood pressure in angiotensin II–hypertensive mice
Kasper Bostlund Assersen, Boye L. Jensen, Camilla Enggaard, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 5, pp. 871-871
Open Access
Dietary sodium, mineralocorticoid receptor, and sex differences in endothelial function
Ishara M.G. Menik, Candee T. Barris, Eric J. Belin de Chantemèle
Elsevier eBooks (2024), pp. 111-122
Closed Access
Mineralocorticoid receptor antagonism prevents coronary microvascular dysfunction in intermittent hypoxia independent of blood pressure
Mohammad Badran, Abdelnaby Khalyfa, Chastidy A. Bailey, et al.
SLEEP (2024)
Closed Access
Endothelial mineralocorticoid receptor ablation confers protection towards endothelial dysfunction in experimental diabetes in mice
Kristina S. Lyngsø, Boye L. Jensen, Pernille Hansen, et al.
Acta Physiologica (2021) Vol. 234, Iss. 2
Open Access | Times Cited: 3
Page 1

Scroll to top